BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide Luis Sanchez-PerezBryan D. ChoiJohn H. Sampson Original Article 17 April 2013 Pages: 983 - 987
Impaired migration of IgA-secreting cells to colon adenocarcinomas Rangarajan V. MuthuswamyPatrik SundströmMarianne Quiding-Järbrink Original Article 17 April 2013 Pages: 989 - 997
Vaccination with anti-idiotype antibody ganglidiomab mediates a GD2-specific anti-neuroblastoma immune response Holger N. LodeManuela SchmidtNikolai Siebert Original Article 17 April 2013 Pages: 999 - 1010
Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models Sandip Pravin PatelAndrew BristolMichael A. Morse Original Article 17 April 2013 Pages: 1011 - 1019
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme Anna Maria Di GiacomoLuana CalabròMichele Maio Original Article 17 April 2013 Pages: 1021 - 1028
The Hedgehog inhibitor cyclopamine impairs the benefits of immunotherapy with activated T and NK lymphocytes derived from patients with advanced cancer Hideya OnishiTakashi MorisakiMitsuo Katano Original Article 17 April 2013 Pages: 1029 - 1039
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer Daniela FenoglioPaolo TraversoGilberto Filaci Original Article 17 April 2013 Pages: 1041 - 1052
Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial Christoph DomschkeYingzi GeFlorian Schuetz Original article 18 April 2013 Pages: 1053 - 1060
Preexisting antitumor immunity augments the antitumor effects of chemotherapy Lingbing ZhangDongdong FengJeffrey A. Norton Original Article 18 April 2013 Pages: 1061 - 1071
Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin Shivani SrivastavaDavid PellosoMichael J. Robertson Original Article 19 April 2013 Pages: 1073 - 1082
Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma Tomar GhansahNasreen VohraShari Pilon-Thomas Original article 19 April 2013 Pages: 1083 - 1091
Antibody–peptide–MHC fusion conjugates target non-cognate T cells to kill tumour cells Ben C. KingAngela D. HamblinMartin J. Glennie Original Article 19 April 2013 Pages: 1093 - 1105
Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer Daniel MazalRichard Lo-ManEduardo Osinaga Original Article 21 April 2013 Pages: 1107 - 1122
Elevated level of peripheral CD8+CD28− T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy Guohong SongXiaoli WangHerbert Kim Lyerly Original Article 21 April 2013 Pages: 1123 - 1130
Highlights of melanoma research presented at the 48th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, June 1–5, 2012 Dorothee HerlynClemens Krepler Meeting Report 16 April 2013 Pages: 1131 - 1135